Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Hybridoma Technology01:31

Hybridoma Technology

17.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

875
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
875
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

464
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
464
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

3.3K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Cold Exposure Improves Glucose Tolerance and Induces Beta-Cell Secretion Response Linked to Lipid Utilization in Young Male with Obesity.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2025
Same author

Regulation of epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: Role of key molecules in tumor differentiation and therapy.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Crosstalk of TGF-β and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review.

Frontiers in endocrinology·2025
Same author

Characterization of Epithelial-Mesenchymal and Neuroendocrine Differentiation States in Pancreatic and Small Cell Ovarian Tumor Cells and Their Modulation by TGF-β1 and BMP-7.

Cells·2024
Same author

[Endocrinology, diabetology and metabolism in the 150 years of the DMW - A long and sustainable relationship].

Deutsche medizinische Wochenschrift (1946)·2024
Same author

Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity.

eLife·2024

Related Experiment Video

Updated: Jan 21, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

[New technologies in diabetes treatment].

Georg Serfling1, Hannes Kalscheuer2, Sebastian M Schmid2

  • 1Medizinische Klinik I und Institut für Endokrinologie und Diabetes, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland. georg.serfling@uksh.de.

Der Internist
|August 4, 2019
PubMed
Summary

New diabetes technology, including hybrid closed-loop systems and advanced continuous glucose monitoring (CGM), stabilizes blood glucose and reduces hypoglycemia. These innovations represent the next step toward an artificial pancreas for improved diabetes management.

Keywords:
Closed loop systemsContinuous glucose monitoringDiabetes mellitus, type 1HypoglycemiaPancreas, artificial

More Related Videos

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
16:59

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Published on: October 10, 2012

12.1K
Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.9K

Related Experiment Videos

Last Updated: Jan 21, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
16:59

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Published on: October 10, 2012

12.1K
Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.9K

Area of Science:

  • Endocrinology and Metabolic Diseases
  • Biomedical Engineering
  • Medical Technology

Background:

  • Technological advancements are transforming diabetes care, offering new diagnostic and therapeutic solutions.
  • Hybrid closed-loop systems, available since 2016 in the USA, mark progress towards automated artificial pancreas technology.
  • Continuous glucose monitoring (CGM) systems are crucial for managing diabetes, with ongoing innovations enhancing their utility.

Purpose of the Study:

  • To provide an overview of recent innovations in continuous glucose monitoring (CGM) systems.
  • To discuss the current status of artificial pancreas development.
  • To highlight the impact of technological progress on diabetes treatment.

Main Methods:

  • Review of current technological advancements in diabetes management.
  • Analysis of the development and features of hybrid closed-loop systems.
  • Examination of new generation continuous glucose monitoring (CGM) devices.

Main Results:

  • Automated basal insulin control in closed-loop systems stabilizes blood glucose, reducing hypoglycemia and improving HbA1c levels.
  • New CGM systems offer increased accuracy, longer wear times (up to 180 days), and no need for daily calibration.
  • While fully automated artificial pancreas systems are still developing, hybrid systems and advanced CGM are already benefiting patients.

Conclusions:

  • Technological innovations, particularly in closed-loop systems and CGM, are significantly improving blood glucose management and reducing complications in diabetes.
  • Advanced CGM systems provide enhanced accuracy and convenience, supporting better long-term glycemic control.
  • The ongoing development of the artificial pancreas promises further automation and improved treatment outcomes for individuals with diabetes, especially type 1 diabetes mellitus.